Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To determine the effects of methylxanthine administration on the incidence of apnea and longer-term clinical outcomes in preterm infants including infants at risk for or having apnea and preterm infants peri-extubation.
CITATION STYLE
Marques, K., Roehr, C. C., Bruschettini, M., Davis, P. G., & Soll, R. (2021). Methylxanthine for the prevention and treatment of apnea in preterm infants. Cochrane Database of Systematic Reviews, 2020(12). https://doi.org/10.1002/14651858.CD013830
Mendeley helps you to discover research relevant for your work.